The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Current Market Overview

• The spatial omics market is expanding swiftly.
• 2023 Market Size: $0.27 billion.
• 2024 Market Size: Expected to reach $0.3 billion, with a CAGR of 11.3%.
• Growth Drivers:
  • Rising number of genetic disorders.
  • Increasing prevalence of cancer.
  • Growing demand for personalized medicine.
  • Rising need for biomarker identification and validation.
  • Increased adoption of spatial genomics, transcriptomics, and proteomics.

Future Market Projections

• The market is set for continued significant growth.
• 2028 Market Size: Expected to reach $0.46 billion, with a CAGR of 11.5%.
• Growth Drivers:
  • Increased research and development activities.
  • Increased financing for OMICS research.
  • Development of transformational approaches for cancer biomarker discovery.
  • Increased translational research.
  • Economic growth.
• Major Trends:
  • Strategic collaborations and partnerships.
  • Advancements in spatial omics techniques.
  • Integration of advanced technologies.
  • Product innovations.
  • Technological advancements.

View More On The Spatial omics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report

Rising Prevalence of Genetic Illnesses Drives Market Growth

Genetic Diseases and Market Impact

• Genetic Diseases: Disorders caused by DNA abnormalities inherited from parents.
• Increasing Factors: Improved diagnostic techniques, lifestyle changes, environmental factors.
• Impact: Spatial omics technologies provide detailed spatial maps of molecular and genetic features within tissues.
• Example:
  • WHO Report (February 2023): Congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year.
  • CDC Report: About 6,000 babies are born with Down syndrome in the US each year, approximately 1 in every 700 babies.
• Conclusion: Rising prevalence of genetic illnesses drives market growth.

Innovations in Spatial Omics Technologies

Technological Advancements

• New Platforms: Companies are developing innovative spatial omics platforms to enhance market position.
• Example:
  • Rebus Biosystems Inc. (March 2021): Launched the Rebus Esper spatial omics platform.
    • Utilizes Synthetic Aperture Optics (SAO) technology.
    • Delivers high-throughput, quantitative, single-molecule, single-cell data with spatial context and subcellular resolution.
    • Enhances spatial analysis depth and accuracy.

Strategic Acquisitions and Collaborations

Bruker Corporation and NanoString Technologies Inc.

• Acquisition Details:
  • Bruker Corporation: Acquired NanoString Technologies Inc. for approximately $392.6 million in cash (May 2024).
  • Purpose: Expand spatial biology portfolio by adding gene expression profiling and spatial transcriptomics solutions.
  • Impact: Strengthens Bruker’s position in the spatial omics market.

Market Segmentation

Product Types and Applications

• By Product:
• By Sample Type:
  • Formalin-Fixed Paraffin-Embedded (FFPE).
  • Fresh Frozen.
• By Workflow:
  • Sample Preparation.
  • Instrumental Analysis.
  • Data Analysis.
• By Technology:
  • Spatial Transcriptomics.
  • Spatial Genomics.
  • Spatial Proteomics.
• By End-Use:
  • Academic and Translational Research Institutes.
  • Pharmaceutical and Biotechnology Companies.

Regional Insights

Geographic Market Dynamics

• Largest Region (2023): North America.
• Fastest-Growing Region (Forecast Period): Asia-Pacific.

The spatial omics market is set for continued growth, driven by rising prevalence of genetic illnesses, advancements in technologies, and strategic acquisitions. With increasing research activities and technological innovations, the market is poised for substantial development in the coming years.

Request A Sample Of The Global Spatial omics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15927&type=smp